170 related articles for article (PubMed ID: 32317216)
1. Candida africana vulvovaginitis: Prevalence and geographical distribution.
Fakhim H; Vaezi A; Javidnia J; Nasri E; Mahdi D; Diba K; Badali H
J Mycol Med; 2020 Sep; 30(3):100966. PubMed ID: 32317216
[TBL] [Abstract][Full Text] [Related]
2. Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single-centre experience in Iran.
Shokoohi G; Javidnia J; Mirhendi H; Rasekh-Jahromi A; Rezaei-Matehkolaei A; Ansari S; Maryami F; Goodarzi S; Romeo O
Mycoses; 2021 Jul; 64(7):771-779. PubMed ID: 33811780
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Candida albicans-closely related yeasts, Candida africana and Candida dubliniensis, in vulvovaginal candidiasis.
Shan Y; Fan S; Liu X; Li J
Med Mycol; 2014 Aug; 52(6):636-40. PubMed ID: 25023482
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Candida africana and Candida dubliniensis, in vulvovaginal candidiasis: First Turkish Candida africana isolates from vulvovaginal candidiasis.
Hazirolan G; Altun HU; Gumral R; Gursoy NC; Otlu B; Sancak B
J Mycol Med; 2017 Sep; 27(3):376-381. PubMed ID: 28641919
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina.
Mucci MJ; Cuestas ML; Landanburu MF; Mujica MT
Rev Iberoam Micol; 2017; 34(2):72-76. PubMed ID: 28385421
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom.
Borman AM; Szekely A; Linton CJ; Palmer MD; Brown P; Johnson EM
J Clin Microbiol; 2013 Mar; 51(3):967-72. PubMed ID: 23303503
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis.
Yazdanparast SA; Khodavaisy S; Fakhim H; Shokohi T; Haghani I; Nabili M; Gholami H; Ahmadi I; Badali H
Mycopathologia; 2015 Dec; 180(5-6):317-23. PubMed ID: 26183965
[TBL] [Abstract][Full Text] [Related]
10. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
[TBL] [Abstract][Full Text] [Related]
11. Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India.
Sharma C; Muralidhar S; Xu J; Meis JF; Chowdhary A
Mycoses; 2014 Sep; 57(9):544-52. PubMed ID: 24697839
[TBL] [Abstract][Full Text] [Related]
12. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis.
Shi Y; Zhu Y; Fan S; Liu X; Liang Y; Shan Y
BMC Infect Dis; 2020 Apr; 20(1):287. PubMed ID: 32393342
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
Fan SR; Liu XP; Li JW
J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
[TBL] [Abstract][Full Text] [Related]
14. Candida africana in recurrent vulvovaginal candidiasis (RVVC) patients: frequency and phenotypic and genotypic characteristics.
Naeimi B; Mirhendi H; Khamisipour G; Sadeghzadeh F; Ahmadi B
J Med Microbiol; 2018 Nov; 67(11):1601-1607. PubMed ID: 30248002
[TBL] [Abstract][Full Text] [Related]
15. Distribution, antifungal susceptibility pattern and intra-Candida albicans species complex prevalence of Candida africana: A systematic review and meta-analysis.
Gharehbolagh SA; Fallah B; Izadi A; Ardestani ZS; Malekifar P; M Borman A; Mahmoudi S
PLoS One; 2020; 15(8):e0237046. PubMed ID: 32817677
[TBL] [Abstract][Full Text] [Related]
16. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
Liu XP; Fan SR; Peng YT; Zhang HP
J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
[TBL] [Abstract][Full Text] [Related]
17. Multilocus sequence typing analysis of Candida africana from vulvovaginal candidiasis.
Zhu YX; Shi Y; Fan SR; Liu XP; Yang J; Zhong SL
BMC Infect Dis; 2019 May; 19(1):461. PubMed ID: 31117966
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
Richter SS; Galask RP; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
J Clin Microbiol; 2005 May; 43(5):2155-62. PubMed ID: 15872235
[TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
Nagashima M; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital.
Gamarra S; Morano S; Dudiuk C; Mancilla E; Nardin ME; de Los Angeles Méndez E; Garcia-Effron G
Mycopathologia; 2014 Oct; 178(3-4):251-8. PubMed ID: 25005365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
